Montréal, QC H4S 1Z9 Canada

+1 (438) 923 9257

Regulatory & Property

Intellectual property and Regulatory Pathways

Our intellectual property policy aims to allow for multiple scenarios for intellectual property rights.  We can guide you to patent experts as well as assisting your organization in registering IP in Canada.

We can guide you on the regulatory process with our in-depth knowledge of Canadian, US and EU policies, and niche experiences to tackle any complex issues associated with new therapies, and support productive interactions with Health Canada, the FDA and the European authorities.

Regulatory Overview

  • The Medicine
  • The Medicine: Safety, Quality and Efficiency
  • The Medicine: Placing on the market
  • Development of various drugs and heath products
  • Over the counter (OTC) and prescription drugs
  • Important and necessary steps in the development of all these products
  • Development cost for a drug (excluding NHP and AHP)
  • Steps to follow in R&D when developing all these products
  • Prescription drugs
  • Over the counter (OTC) drugs
  • Natural Health Products (NHP)
  • Veterinary Medicine
  • Animal Health Products (AHP)

Contact us for more information.


7171 Frederick Banting,

Centre d’innovation adMare/

adMare Bioinnovations

Montréal, QC H4S 1Z9



: (438) 923-9257

9h – 17h

Partenaires financier/Financial Partners